Gene Logic Garners NCI Contract for Preclinical Toxicology Studies | GenomeWeb

Gene Logic Garners NCI Contract for Preclinical Toxicology Studies

Apr 08, 2004

NEW YORK, April 8 (GenomeWeb News) - Gene Logic today said it has been tapped by the National Cancer Institute's Division of Cancer Treatment and Diagnosis to provide it with preclinical safety and pharmacology studies pertinent to its core cancer, AIDS, and AIDS-related illness research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

The Apple's Journey

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

This Week in Nature

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Change Is Hard to Do

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

Possible Paths for CUP

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.